โšก 651.5 ยท Lipid Myopathies

Nelson Textbook of Pediatrics 22nd Edition โ€” Disorders of fatty acid oxidation and carnitine metabolism. CPT2 deficiency (most common cause of recurrent myoglobinuria), VLCAD deficiency, primary systemic carnitine deficiency (SLC22A5), MADD (ETFDH, multiple acyl-CoA dehydrogenase deficiency). Triggers: fasting, prolonged exercise, cold, high-fat meals, infection. Diagnosis: acylcarnitine profile, muscle biopsy (lipid droplets), genetic testing.

๐ŸŒ paeds.online โ€” Pakistan's Pediatric Platform

๐Ÿ“‹ 30 Clinical Scenarios โ€” Lipid Myopathies (Fatty Acid Oxidation & Carnitine Disorders)

๐Ÿ“‡ Highโ€‘Yield Review Cards โ€” Lipid Myopathies

๐Ÿฉบ Clinical Recognition: Lipid Myopathies

Select a presentation for diagnostic clues and management.

๐Ÿ“‹ Stepwise Management of Lipid Myopathies

    โšก Reflex Prompts โ€” Clinical Decisions

    ๐Ÿ“Š Key Tables โ€” Lipid Myopathies

    Disorders of Lipid Metabolism with Myopathy

    DisorderGeneAcylcarnitine PatternTriggersBaseline CKTreatment
    CPT2 deficiencyCPT2C16, C18:1 elevatedProlonged exercise, fasting, cold, high-fat meal, febrile illnessNormalLow-fat diet, avoid fasting, IV glucose during illness, carnitine, medium-chain triglycerides (MCT)
    VLCAD deficiencyACADVLC14:1 elevatedFasting, prolonged exercise, cold, feverNormalAvoid fasting, MCT oil, carnitine, IV glucose during illness
    Primary systemic carnitine deficiencySLC22A5 (OCTN2)Low free carnitine, low acylcarnitinesHypoglycemia, cardiomyopathy, weaknessNormal-mild elevationOral L-carnitine (100-400 mg/kg/day), avoid fasting
    Muscle carnitine deficiencyUnknown (SLC22A5 usually systemic)Normal serum carnitine, low muscle carnitineProgressive proximal weaknessMild elevationOral L-carnitine (variable response)
    Multiple acyl-CoA dehydrogenase deficiency (MADD)ETFDH, ETFA, ETFBMultiple acyl-carnitines (C4-C18:1)Exercise, fasting, infectionMild-moderate elevationRiboflavin (some responsive), carnitine, low-fat diet, avoid fasting
    LCHAD / TFP deficiencyHADHA, HADHB3-hydroxy C16, C18 acylcarnitinesHypoglycemia, cardiomyopathy, rhabdomyolysisNormalLow-fat diet, MCT, avoid fasting, carnitine
    MCAD deficiencyACADMC8 elevatedFasting (hypoglycemia), less myopathyNormalAvoid fasting, cornstarch, IV glucose during illness
    ๐Ÿ”ฌ Diagnostic Approach to Lipid Myopathies

    History: Recurrent rhabdomyolysis (myoglobinuria, CK >10,000) triggered by fasting, prolonged exercise, cold, high-fat meal, febrile illness. Normal baseline CK between episodes.

    Acylcarnitine profile (blood spot): Key diagnostic test. Elevations of specific species (C14:1 in VLCAD, C16/C18:1 in CPT2, low free carnitine in systemic carnitine deficiency).

    Muscle biopsy: Increased lipid droplets (oil red O stain) in type I fibers.

    Treatment principles: Avoid fasting, avoid high-fat meals (for CPT2/VLCAD), maintain glucose during illness (IV D10), MCT oil (bypasses long-chain FAO defects), carnitine supplementation (except in CPT2? careful โ€” can increase acylcarnitines; usually safe, but evidence limited).

    Data from Nelson 651.5; Manzur AY. Lipid myopathies.

    ๐Ÿ“– Summary: Lipid Myopathies โ€” Nelson 651.5